GDS Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,443
Closed -$768K 172
2024
Q4
$768K Hold
8,443
0.07% 96
2024
Q3
$876K Hold
8,443
0.09% 75
2024
Q2
$819K Sell
8,443
-9
-0.1% -$830 0.09% 65
2024
Q1
$761K Hold
8,452
0.09% 70
2023
Q4
$674K Buy
8,452
+9
+0.1% +$677 0.09% 68
2023
Q3
$600K Hold
8,443
0.09% 65
2023
Q2
$650K Hold
8,443
0.11% 69
2023
Q1
$634K Hold
8,443
0.11% 66
2022
Q4
$665K Sell
8,443
-12
-0.1% -$900 0.13% 68
2022
Q3
$594K Buy
+8,455
New +$663K 0.13% 64

Other funds holding CL

GDS Wealth Management's CL Position: Q1 2025 in Review

GDS Wealth Management sold out of Colgate-Palmolive (CL) in Q1 2025, closing a stake of 8,443 shares — an estimated $768K sold.

GDS Wealth Management first reported a position in CL in Q3 2022 and held it in 10 quarters. The position peaked at $876K in Q3 2024. 1,942 funds tracked by Wall St. Rank hold CL as of Q1 2025.

  • GDS Wealth Management reported no remaining Colgate-Palmolive position as of Q1 2025 after selling out during the quarter.
  • GDS Wealth Management sold 8,443 Colgate-Palmolive shares in Q1 2025, an estimated $768K.
  • GDS Wealth Management first reported a position in Colgate-Palmolive in Q3 2022 and held it in 10 quarters.
  • GDS Wealth Management's Colgate-Palmolive position peaked at $876K in Q3 2024.
  • 1,942 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2025.

Based on GDS Wealth Management's 13F filing for Q1 2025, filed 14 May 2025.